AM Diabetes & Endocrinology Center

Bartlett, Tennessee 38133-4063

0 studies enrolling now · 8 studies all time

What they study most

Diabetes Mellitus, Insulin-Dependent, Diabetes Mellitus, Type 2, Juvenile Diabetes, Type 1 Diabetes, Type 1 Diabetes Mellitus, Type 2 Diabetes, Type2 Diabetes Mellitus

Studies at this site

• Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3) — Running, not enrolling
• PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM) — Completed
• Description of Patients With Type 1 Diabetes Treated With Teplizumab — Completed
• A Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (>=10 to <18 Years) With Type 2 Diabetes Mellitus — Completed
• Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System — Completed
• Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus — Stopped early
• Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics — Completed
• Efficacy and Safety Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Adults — Completed